Dr. Darwin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
300 Pasteur Drive
Lane L154
Palo Alto, CA 94305Phone+1 973-897-5738- Is this information wrong?
Education & Training
- University of South Florida College of MedicineClass of 2022
- Arizona State UniversityBS, Biochemistry, Summa Cum Laude, 2014 - 2018
Certifications & Licensure
- CA State Medical License 2023 - 2025
Publications & Presentations
PubMed
- 5 citationsIncidence and Management of Effusions Before and After CD19-Directed Chimeric Antigen Receptor (CAR) T Cell Therapy in Large B Cell Lymphoma.Abu-Sayeef Mirza, Ambuj Kumar, Hamza Hashmi, Franco Garcia, Constantine Logothetis
Transplantation and Cellular Therapy. 2021-03-01 - 26 citationsVenous thromboembolism associated with CD19-directed CAR T-cell therapy in large B-cell lymphomaHamza Hashmi, Abu-Sayeef Mirza, Alicia Darwin, Constantine Logothetis, Franco Garcia
Blood Advances. 2020-09-08 - 6 citationsCarfilzomib-induced atypical haemolytic uraemic syndrome: a diagnostic challenge and therapeutic success.Alicia Darwin, Leonger Malpica, Jugraj Dhanoa, Hamza Hashmi
BMJ Case Reports. 2021-02-26
Abstracts/Posters
- Increased risk of immune-related hepatitis among adolescent and young adults (AYAs) with melanoma during immunotherapy with checkpoint inhibitors (ICIs)Darwin A, Reed D, Tanvetyanon T, American Society of Clinical Oncology (ASCO), Virtual, 6/2021
- Incidence and Management of Venous Thrombo-Embolism (VTE) Associated with CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy: A Single Institution ExperienceHamza Hashmi MD, Abu-Sayeef Mirza MD, MPH, Alicia Darwin, Constantine Logothetis MD, Franco Garcia MD, Anuhya Kommalapati MD, Christina A. Bachmeier PharmD, BCOP, Juli..., Biology of Blood and Marrow Transplant, 3/2020
- Hypofibrinogenemia in Patients Receiving CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Large B Cell Lymphoma: A Single Institution ExperienceHamza Hashmi MD, Abu-Sayeef Mirza MD, MPH, Alicia Darwin, Constantine Logothetis MD, Franco Garcia MD, Anuhya Kommalapati MD, Christina A. Bachmeier PharmD, BCOP, Kaar..., Biology of Blood and Marrow Transplantation, 3/2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: